EMA Clarifies Questions Over Biosimilar Interchangeability

Q&A Document Follows EMA-HMA Statement On Scientific Rationale Last Year

 
• By David Wallace
  
EU Flag With Question Mark
The EMA has answered questions around biosimilar interchangeability • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics